G
Gerald T. Nepom
Researcher at Benaroya Research Institute
Publications - 349
Citations - 18821
Gerald T. Nepom is an academic researcher from Benaroya Research Institute. The author has contributed to research in topics: Human leukocyte antigen & Antigen. The author has an hindex of 77, co-authored 337 publications receiving 17727 citations. Previous affiliations of Gerald T. Nepom include Washington University in St. Louis & Bristol-Myers Squibb.
Papers
More filters
Journal ArticleDOI
MHC Class-II Molecules and Autoimmunity
Gerald T. Nepom,H Erlich +1 more
TL;DR: Molecular and genetic studies of HLA class-II genes provide new insights into the basis for MHC associations with autoimmunity and suggest a number of possible mechanisms critical for autoimmune triggering events involving class- II molecules.
Journal ArticleDOI
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Christine Beeton,Heike Wulff,Nathan Standifer,Philippe Azam,Katherine M. Mullen,Michael W. Pennington,Aaron Kolski-Andreaco,Eric Wei,Alexandra Grino,Debra Counts,Ping H. Wang,Christine J. LeeHealey,Brian S. Andrews,Ananthakrishnan Sankaranarayanan,Daniel Homerick,Werner W. Roeck,Jamshid Tehranzadeh,Kimber L. Stanhope,Pavel I. Zimin,Peter J. Havel,Stephen M Griffey,Hans Guenther Knaus,Gerald T. Nepom,George A. Gutman,Peter A. Calabresi,K. George Chandy +25 more
TL;DR: It is demonstrated that disease-associated autoreactive T cells from patients with type-1 diabetes mellitus or rheumatoid arthritis are mainly CD4+CCR7−CD45RA− effector memory T cells (TEM cells) with elevated Kv1.3 potassium channel expression, which ameliorate pristane-induced arthritis in rats and reduce the incidence of experimental autoimmune diabetes in diabetes-prone rats.
Journal ArticleDOI
Genetics of Type 1A Diabetes
TL;DR: Recent advances in knowledge of the genetics of type 1 diabetes are reviewed and it is shown how this information could find clinical applications of considerable consequence.
Journal ArticleDOI
Narcolepsy is strongly associated with the T-cell receptor alpha locus.
Joachim Hallmayer,Juliette Faraco,Ling Lin,Stephanie Hesselson,Juliane Winkelmann,Minae Kawashima,Minae Kawashima,Geert Mayer,Giuseppe Plazzi,Sona Nevsimalova,Patrice Bourgin,Sheng Seung-Chul Hong,Yutaka Honda,Makoto Honda,Birgit Högl,William T. Longstreth,Jacques Montplaisir,David Kemlink,Mali Einen,Justin Chen,Stacy L. Musone,Matthew Akana,Taku Miyagawa,Jubao Duan,Alex Desautels,Christine Erhardt,Per Egil Hesla,Francesca Poli,Birgit Frauscher,Jong-Hyun Jeong,Sung-Pil Lee,Thanh G.N. Ton,Mark N. Kvale,Libor Kolesar,Marie Dobrovolna,Gerald T. Nepom,Daniel R. Salomon,H-Erich Wichmann,Guy A. Rouleau,Christian Gieger,Douglas F. Levinson,Pablo V. Gejman,Pablo V. Gejman,Thomas Meitinger,Terry Young,Paul E. Peppard,Katsushi Tokunaga,Pui-Yan Kwok,Neil Risch,Neil Risch,Emmanuel Mignot,Emmanuel Mignot +51 more
TL;DR: The authors found association between narcolepsy and polymorphisms in the TRA@ (T-cell receptor alpha) locus, with highest significance at rs1154155 (average allelic odds ratio 1.69, genotypic odds ratios 1.94 and 2.55, P < 10(-21), 1,830 cases, 2,164 controls).
Journal ArticleDOI
MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.
TL;DR: Soluble tetramerized class II MHC molecules, loaded with an immunodominant peptide from hemagglutinin (HA) and labeled with fluorescent dyes, were constructed and used to directly identify antigen-specific T cells from influenza-immune individuals.